Correction to: Cross-sectional study of medical advertisements in a national general medical journal: evidence, cost, and safe use of advertised versus comparative drugs,Research Integrity and Peer Review

当前位置： X-MOL 学术 › Research Integrity and Peer Review › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Correction to: Cross-sectional study of medical advertisements in a national general medical journal: evidence, cost, and safe use of advertised versus comparative drugs
Research Integrity and Peer Review Pub Date : 2021-06-11 , DOI: 10.1186/s41073-021-00114-6
Kim Boesen , Anders Lykkemark Simonsen , Karsten Juhl Jørgensen , Peter C. Gøtzsche

Correction to: Res Integr Peer Rev 6, 8 (2021)

https://doi.org/10.1186/s41073-021-00111-9

Following publication of the original article [1], the authors noted that an incorrect file for Supplementary file 1 had been published. The corrected version of Supplementary file 1 is attached to this Correction and it has also been updated in the original article, accordingly.

1.
Boesen, et al. Cross-sectional study of medical advertisements in a national general medical journal: evidence, cost, and safe use of advertised versus comparative drugs. Res Integr Peer Rev. 2021;6:8. https://doi.org/10.1186/s41073-021-00111-9.
Article Google Scholar

Download references

Affiliations

Nordic Cochrane Centre, Rigshospitalet Dept. 7811, 2100, Copenhagen, Denmark
Kim Boesen, Anders Lykkemark Simonsen & Karsten Juhl Jørgensen
Current address: Meta Research Innovation Center Berlin (METR IC-B), Berlin Institute of Health, Charité Universitätsmedizin, QUEST Center for Transforming Biomedical Research, Berlin, Germany
Kim Boesen
Centre for Evidence-Based Medicine (CEBMO) and Cochrane Denmark, Dept. Clinical Research, University of Southern Denmark, Odense, Denmark
Karsten Juhl Jørgensen
Open Patient data Exploratory Network (OPEN), Odense University Hospital, Odense, Denmark
Karsten Juhl Jørgensen
Institute for Scientific Freedom, 2970, Copenhagen, Denmark
Peter C. Gøtzsche

Authors

Kim BoesenView author publications
You can also search for this author in PubMed Google Scholar
Anders Lykkemark SimonsenView author publications
You can also search for this author in PubMed Google Scholar
Karsten Juhl JørgensenView author publications
You can also search for this author in PubMed Google Scholar
Peter C. GøtzscheView author publications
You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kim Boesen.

Additional file 1.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

Cite this article

Boesen, K., Simonsen, A.L., Jørgensen, K.J. et al. Correction to: Cross-sectional study of medical advertisements in a national general medical journal: evidence, cost, and safe use of advertised versus comparative drugs. Res Integr Peer Rev 6, 10 (2021). https://doi.org/10.1186/s41073-021-00114-6

Download citation

Published: 11 June 2021
DOI: https://doi.org/10.1186/s41073-021-00114-6

中文翻译：

更正：全国综合医学期刊中医学广告的横断面研究：广告与比较药物的证据、成本和安全使用

更正：Res Integr Peer Rev 6, 8 (2021)

https://doi.org/10.1186/s41073-021-00111-9

在原始文章 [1] 发表后，作者指出补充文件 1 的错误文件已发表。补充文件 1 的更正版本附在本更正后，并相应地在原始文章中进行了更新。

1.
博森等人。国家综合医学期刊中医学广告的横断面研究：广告与比较药物的证据、成本和安全使用。Res Integr Peer Rev. 2021；6:8。https://doi.org/10.1186/s41073-021-00111-9。
文章谷歌学术

下载参考

隶属关系

Nordic Cochrane Centre, Rigshospitalet Dept. 7811, 2100, 哥本哈根, 丹麦
Kim Boesen、Anders Lykkemark Simonsen 和 Karsten Juhl Jørgensen
当前地址：柏林元研究创新中心 (METR IC-B)，柏林卫生研究所，Charité Universitätsmedizin，QUEST 生物医学研究转化中心，柏林，德国
金宝森
循证医学中心 (CEBMO) 和 Cochrane Denmark，临床研究部，南丹麦大学，丹麦欧登塞
Karsten Juhl Jørgensen
开放患者数据探索网络 (OPEN)，欧登塞大学医院，丹麦欧登塞
Karsten Juhl Jørgensen
科学自由研究所，2970，丹麦哥本哈根
Peter C. Gøtzsche

作者

Kim Boesen查看作者出版物
您也可以在PubMed Google Scholar中搜索此作者
Anders Lykkemark Simonsen查看作者出版物
您也可以在PubMed Google Scholar中搜索此作者
Karsten Juhl Jørgensen查看作者出版物
您也可以在PubMed Google Scholar中搜索此作者
Peter C. Gøtzsche查看作者出版物
您也可以在PubMed Google Scholar中搜索此作者

通讯作者

与金宝森的通信。

附加文件 1.

开放获取本文根据知识共享署名 4.0 国际许可协议获得许可，该许可允许以任何媒体或格式使用、共享、改编、分发和复制，只要您适当注明原作者和来源，提供链接到知识共享许可，并指出是否进行了更改。本文中的图像或其他第三方材料包含在文章的知识共享许可中，除非在材料的信用额度中另有说明。如果文章的知识共享许可中未包含材料，并且您的预期用途未得到法律法规的允许或超出允许的用途，则您需要直接从版权所有者处获得许可。要查看此许可证的副本，请访问 http://creativecommons.org/licenses/by/4.0/。

重印和许可

引用这篇文章

Boesen, K.、Simonsen, AL、Jørgensen、KJ等。更正为：全国通用医学期刊中医学广告的横断面研究：广告与比较药物的证据、成本和安全使用。Res Integr Peer Rev 6, 10 (2021)。https://doi.org/10.1186/s41073-021-00114-6

下载引文